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Volume 52, Number 5 Abstracts 1421or who died at 6 months of their initial VTE. Included patients were
monitored with clinical examination at 3, 6, and 12 months and annually for
at least 5 years. Patients with proximal DVT were anticoagulated for at least
6 months. Those with calf DVT were anticoagulated for 3 months or were
monitored with ultrasound imaging for 3 weeks. If the calf DVT progressed,
the patients were anticoagulated; if it did not, they remained on compression
stockings and aspirin or nonsteroidal anti-inflammatory drugs. Patients
underwent duplex ultrasound imaging at least twice in the first year and at
any time when there were symptoms suggestive of recurrent VTE. Duplex
examinations were also performed at 5 years and anytime later for those with
longer follow-up. DVT recurrence was defined as thrombus in a new
location from the original DVT when the extent of thrombus at the follow
up examination was 9 cm, when a previously recanalized segment subse-
quently exhibited non-compressibility, and when thrombus thickness was
2 mm for distal veins and 4 mm for proximal veins. This prospective
observational study enrolled 153 consecutive patients. Location and extent
of the initial DVT, PE, recurrent VTE, causes of mortality, signs and
symptoms of post-thrombotic syndrome, and risk factors of VTE were
recorded.
Recurrent VTE occurred in 26.1% by 5 years. Patients who had both
proximal and distal DVT had similar recurrence rates compared with those
patients with proximal DVT alone (17 of 48 [35%] vs 12 of 49 [24%], P 
.27). There appeared to be a trend toward higher recurrence rates in patients
with proximal and distal DVT than those with calf DVT alone (P  .08). A
higher recurrence was associated with unprovoked DVT (relative risk [RR],
2.9; 95% confidence interval [CI], 1.5-5.7; P .01) and age65 years (RR,
1.5; 95% CI, 1-23; P .025;). There was no demonstrated increased risk of
recurrence with thrombophilia (P  .21). There was low recurrence in
patients with DVT associated with surgery or trauma (P  .001). Increased
severity of post thrombotic syndrome was associated with ipsilateral recur-
rence (RR, 1.6; 95%CI, 1.4-2.2; P .001). PE was diagnosed 47 times, and
12 of 47 (25%) incidences of PE were fatal.
Comment: The study has severe limitations due to sample size. The
number of patients is too small to provide meaningful subgroup analysis.
The number of patients ultimately dying of PE is a bit shocking, but perhaps
what is most interesting in this field is the increasing frequency of reports
contradicting the widely held belief that thrombophilia is a risk factor for
recurrence of VTE. Clearly, as in this study, many patients with thrombo-
philia have other risk factors for VTE that make it difficult to independently
assess the impact of thrombophilia on VTE recurrence. Despite the results
here, until larger and better studies have examined the impact of thrombo-
philia on VTE recurrence, it may be best to still consider thrombophilia as a
risk factor for recurrent VTE.
Relation Between Preoperative and Intraoperative New Wall Motion
Abnormalities in Vascular Surgery Patients: A Transesophageal Echo-
cardiographic Study
Galal W, Hoeks SE, Flu WJ, et al. Anesthesiology 2010;112:557-66.
Conclusion: There is a poor correlation between new wall motion
abnormalities (NWMAs) observed intraoperatively using transesophageal
echocardiography (TEE) and preoperative stress-induced NWMAs assessed
by dobutamine echocardiography.
Summary: Intraoperative TEE can detect regional wall motion abnor-
malities in patients undergoing major noncardiac surgery. However, it is
unclear whether NWMAs detected intraoperatively with TEE actually cor-
relate with abnormalities detected preoperatively with noninvasive stress
testing. The authors sought to determine whether wall motion abnormali-
ties identified with dobutamine echocardiography correlate with those ob-
served intraoperatively with TEE.
Fifty-four patients undergoing major vascular surgery underwent pre-
operative dobutamine echocardiography and intraoperative TEE. A seven-
wall model scoring system was used to determine the locations of left
ventricular rest wall motion abnormalities and NWMAs discovered with
preoperative stress testing or with intraoperative TEE. Postoperative cardiac
troponin levels, myocardial infarction, and cardiac death were noted during
a 30-day follow-up. Wall motion abnormalities at rest were detected by
dobutamine echocardiography in 17 patients (31%). TEE noted NWMAs in
16 patients (30%). NWMAs were induced with dobutamine in 17 patients
(31%). NWMAs were observed by TEE in 23 patients (43%,   0.65).
There was excellent agreement between preoperative and intraoperative rest
wall motion abnormalities (  0.92); however, agreement for preoperative
and intraoperative new wall motion abnormalities in different locations was
poor (  0.26-0.44). A composite cardiac end point of increased troponin
levels, myocardial infarction, or cardiac death occurred in 15 patients (26%),
of whom 10 patients (67%) experienced both preoperative and intraopera-
tive NWMAs. Only intraoperative NWMAs were observed in four (27%). In
the six patients who experienced a postoperative myocardial infarction, the
location of the electrocardiographic changes correlated with intraoperatively
observed NWMAs by TEE.
Comment: In this series there were no cardiac deaths or postoperative
myocardial infarctions in patients without intraoperative NWMAs. Because
reproducibility of wall motion abnormalities at different perioperative timeswas not achievable in this study, the suggestion is that optimized medical
therapy remains superior over invasive interventions focused on preoperative
detection of culprit lesions. The data indicate patients with intraoperative
NWMAs detected by TEE are perhaps the highest risk group for periopera-
tively significant cardiac events. Such patients demand perhaps the most
assiduous perioperative management of cardiac parameters.
Risk Factors and Outcome of New-Onset Cardiac Arrhythmias in
Vascular Surgery Patients
Winkle TA, Schouten O, Hoeks SE, et al. Am Heart J 2010;159:1108-15.
Conclusion: Perioperative arrhythmias are common after vascular
surgeries. Elderly patients and those with reduced left ventricular function
are particularly prone to postoperative arrhythmias.
Summary:Cardiac arrhythmia occurring postoperatively can be seen in
up to 20% of patients undergoing noncardiac surgery (Brathwaite D, et al,
Chest 1998;114:462-8 and Walsh SR et al, Ann R Coll Surg Engl 2007;89:
91-5). The risk of cardiovascular events is especially elevated in noncardiac
vascular surgical patients (Schouten O et al, Eur Heart J 2008;29:283-4).
Many events are asymptomatic and often transient and unpredictable, sug-
gesting the true prevalence may be underestimated. The current study
focused on vascular surgical patients and was designed to determine the true
prevalence of cardiac arrhythmias in this population, identify operative risk
factors leading to new-onset cardiac arrhythmias, and assess the impact of
these new arrhythmias on postoperative outcome.
The study included 515 vascular surgical patients without a history of
arrhythmia. Assessed were left ventricular function (LVF), determined by
N-terminal pro-B-type natriuretic peptide levels and echocardiography,
inflammatory status, and cardiac risk factors. New onset arrhythmias and
ischemia were identified with 72-hour continuous electrocardiographic
recordings. Patients were evaluated for atrial fibrillation, sustained ventric-
ular tachycardia, supraventricular tachycardia, and ventricular fibrillation.
There was a new onset of arrhythmia in 55 patients (11%), including atrial
fibrillation in 4%, ventricular tachycardia in 7%, supraventricular tachycardia
in 1%, and ventricular fibrillation in 0.2%. Arrhythmia was preceded by
ischemia in 10 of 55 patients. Reduced LVF and increased age were risk
factors for development of arrhythmia. Multivariant analysis indicated that
perioperative arrhythmias were associated with long-term cardiovascular
events independent of perioperative ischemia (hazard ratio, 2.2; 95% confi-
dence interval, 1.3-3.8; P  .004).
Comment:More than 30 years ago, Goldman published a prospective
series of patients undergoing major noncardiac surgery, and only 4% devel-
oped postoperative supraventricular arrhythmias (Goldman L, Chest 1978;
73:450-4). One conclusion was that postoperative supraventricular arrhyth-
mias were often transient, and the most important thing was to correct the
cause of the arrhythmia. The number of each type of arrhythmia occurring in
this study did not permit meaningful subset analysis. The association of
arrhythmias with older age and preoperatively decreased LVF is not all that
surprising. Currently, many vascular surgical patients are routinely subjected
to telemetry monitoring. Given the number of arrhythmias identified in this
study, the current data may question the use of such a blanket policy for
patients without known preoperative left ventricular dysfunction.
The Phosphodiesterase Inhibitor Cilostazol Induces Regression of
Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus
Principal Results of the Diabetic Atherosclerosis Prevention by Cilosta-
zol (DAPC) Study: A Randomized Trial
Katakami N, Kim Y-S, Kawamori R, et al. Circulation 2010;121:2584-91.
Conclusion: Cilostazol provides greater inhibition of progression of
carotid intima-medial thickness than aspirin in patients with type 2 diabetes
mellitus.
Summary: It appears patients with diabetes without previous myocar-
dial infarction have as high a risk of myocardial infarction as patients without
diabetes and previous myocardial infarction (Haffner SM, et al, N Engl
J Med 1998;339:229-34). On the basis of this, some have advocated that
primary prevention in patients with diabetes may be indicated. Guidelines
suggest that individuals with risk factors for coronary heart disease, such as
diabetes mellitus, should take aspirin for primary and secondary prevention,
although the ability of aspirin to effectively serve as a primary preventive
agent is controversial (American Diabetes Association, Diabetes Care 2007;
30:s4-41). There has been some suggestion that cilostazol may be effective
in preventing cardiovascular events in patients with type 2 diabetes mellitus
(Shinohara Y, et al, Cerebrovasc Dis 2008;26:63-70). This study therefore
compared the ability of two antiplatelet agents, aspirin and cilostazol, to
prevent progression of carotid intima-media thickness. This was a prospec-
tive, randomized, open, blinded end point study conducted in four East
Asian countries. The study enrolled 329 type 2 diabetic patients suspected of
peripheral arterial disease (PAD). Patients were eligible if they were aged 40
to 85 years at the time of enrollment and were suspected of PAD on the basis
of an ankle-brachial index 1.0, poor pulses, or clinical symptoms of PAD.
Patients were allocated to receive aspirin (81-100 mg/d) or cilostazol
